Free Trial
NYSE:GBS

GBS (GBS) Stock Price, News & Analysis

$1.50
+0.09 (+6.38%)
(As of 07/26/2024 ET)
Today's Range
$1.42
$1.50
50-Day Range
$1.38
$2.45
52-Week Range
$0.36
$2.89
Volume
20,250 shs
Average Volume
955,325 shs
Market Capitalization
$22.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GBS stock logo

About GBS Stock (NYSE:GBS)

GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

GBS Stock Price History

GBS Stock News Headlines

625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Covid-19 vaccines: serious adverse events explained
See More Headlines
Receive GBS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/31/2022
Today
7/26/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-8,310,000.00
Pretax Margin
-1,907.09%

Debt

Sales & Book Value

Annual Sales
$440,000.00
Book Value
$0.44 per share

Miscellaneous

Free Float
14,850,000
Market Cap
$22.34 million
Optionable
Not Optionable
Beta
1.32
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives


GBS Stock Analysis - Frequently Asked Questions

How have GBS shares performed this year?

GBS's stock was trading at $0.3379 at the beginning of the year. Since then, GBS stock has increased by 343.9% and is now trading at $1.50.
View the best growth stocks for 2024 here
.

How were GBS's earnings last quarter?

GBS Inc. (NYSE:GBS) posted its quarterly earnings data on Wednesday, August, 31st. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.04.

How do I buy shares of GBS?

Shares of GBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:GBS) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners